Trade this ETF at your broker
Index | MSCI ACWI IMI Innovation Select ESG Screened 200 |
Investment focus | Equity, World, Social/Environmental |
Fund size | EUR 7 m |
Total expense ratio | 0.30% p.a. |
Replication | Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Long-only |
Sustainability | Yes |
Fund currency | USD |
Currency risk | Currency unhedged |
Volatility 1 year (in EUR) | 15.18% |
Inception/ Listing Date | 12 July 2022 |
Distribution policy | Accumulating |
Distribution frequency | - |
Fund domicile | Ireland |
Fund Provider | Xtrackers |
Fund Structure | Company With Variable Capital (SICAV) |
UCITS compliance | Yes |
Administrator | State Street Custodial Services (Ireland) Limited |
Investment Advisor | DWS Investments UK Ltd |
Custodian Bank | State Street Custodial Services (Ireland) Limited |
Revision Company | Pricewaterhouse Coopers |
Fiscal Year End | 31 December |
Swiss representative | DWS CH AG |
Swiss paying agent | Deutsche Bank (Suisse) SA |
Tax data | Bundesanzeiger | |
Germany | 30% tax rebate | |
Switzerland | ESTV Reporting | |
Austria | Tax Reporting Fund | |
UK | UK Reporting |
Indextype | - |
Swap counterparty | - |
Collateral manager | |
Securities lending | Yes |
Securities lending counterparty |
NVIDIA | 5.44% |
Gilead Sciences | 4.51% |
Microsoft | 4.42% |
Visa | 4.39% |
Mastercard | 4.35% |
Vertex Pharmaceuticals | 4.21% |
Apple | 4.09% |
Tesla | 3.65% |
AMD | 3.35% |
Moderna | 3.03% |
Broker | Rating | Savings plan offer | Account fee | More information |
---|---|---|---|---|
free of charge | free of charge | More info | ||
free of charge | free of charge | More info | ||
free of charge | free of charge | More info | ||
free of charge | free of charge | More info | ||
free of charge | free of charge | More info |
YTD | +6.23% |
1 month | -3.67% |
3 months | +2.99% |
6 months | +16.57% |
1 year | +22.95% |
3 years | - |
5 years | - |
Since inception (MAX) | +19.96% |
2023 | +27.60% |
2022 | - |
2021 | - |
2020 | - |
Volatility 1 year | 15.18% |
Volatility 3 years | - |
Volatility 5 years | - |
Return per risk 1 year | 1.51 |
Return per risk 3 years | - |
Return per risk 5 years | - |
Maximum drawdown 1 year | -11.55% |
Maximum drawdown 3 years | - |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | -23.19% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
gettex | EUR | XNNV | - - | - - | - |
Borsa Italiana | EUR | XNNV | XNNV IM XNNVEUIV | XNNV.MI XNNVEURINAV=SOLA | |
London Stock Exchange | USD | XNNV | XNNV LN XNNVUSIV | XNNV.L XNNVUSDINAV=SOLA | |
London Stock Exchange | GBP | XNNS | XNNS LN XNNVCHIV | XNNS.L XNNVCHFINAV=SOLA | |
SIX Swiss Exchange | CHF | XNNV | XNNV SW XNNVGBIV | XNNV.S XNNVGBPINAV=SOLA | |
XETRA | EUR | XNNV | XNNV GR | XNNV.DE |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
iShares Healthcare Innovation UCITS ETF | 983 | 0.40% p.a. | Accumulating | Sampling |
Lyxor MSCI Disruptive Technology ESG Filtered (DR) UCITS ETF - Acc | 149 | 0.45% p.a. | Accumulating | Full replication |
WisdomTree Megatrends UCITS ETF USD | 9 | 0.50% p.a. | Accumulating | Full replication |
VanEck Genomics and Healthcare Innovators UCITS ETF A | 6 | 0.35% p.a. | Accumulating | Full replication |
L&G Global Thematic ESG Exclusions UCITS ETF USD Accumulating | 4 | 0.60% p.a. | Accumulating | Sampling |